07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Access AccuTnl+3 troponin I assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for...
07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Elecsys Troponin T high-sensitive assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for the early rule out...
07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Architect Stat High Sensitive Troponin-I Assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott for the early rule out of...
08:00 , Jan 28, 2013 |  BC Week In Review  |  Clinical News

Architect Stat High Sensitive Troponin-I Assay regulatory update

Abbott said it received CE Mark approval for its Architect Stat High Sensitive Troponin-I Assay to quantitatively determine cardiac troponin I levels in human plasma and serum. Abbott said cardiac troponin I values are used...